Spero Therapeutics
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $258 | $39,658 | $3,048 | $11,802 |
Gross Profit | 258 | 39,658 | 3,048 | 11,802 |
EBITDA | -7,203 | 31,781 | -7,328 | -2,360 |
EBIT | -7,329 | -2,361 | ||
Net Income | -7,203 | 31,520 | -7,382 | -1,700 |
Net Change In Cash | 258 | 39,658 | 3,048 | 11,802 |
Free Cash Flow | 15,864 | -8,351 | 17,422 | -17,693 |
Cash | 56,129 | 40,265 | 48,616 | 31,194 |
Basic Shares | 57,281 | 59,368 | 56,280 | 56,026 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $59,619 | $47,977 | $103,781 | $48,579 |
Gross Profit | 59,619 | -48,780 | 52,341 | 48,579 |
EBITDA | 8,833 | -72,482 | 27,154 | -42,941 |
EBIT | -72,484 | 26,787 | -43,810 | |
Net Income | 8,572 | -68,566 | 22,806 | -46,415 |
Net Change In Cash | 59,619 | 47,977 | 103,781 | 48,579 |
Free Cash Flow | -12,624 | -23,444 | -32,995 | -7,731 |
Cash | 40,265 | 52,889 | 76,333 | 109,107 |
Basic Shares | 59,039 | 54,037 | 52,989 | 37,585 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.12 |
2025-12-31 | $0.53 |
2025-09-30 | -$0.13 |
2025-06-30 | -$0.03 |